Skip to content

New anti-reflux and bariatric surgery for the treatment of obesity complicated with gastroesophageal reflux disease

New anti-reflux and bariatric surgery for the treatment of obesity complicated with gastroesophageal reflux disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015952
Enrollment
Unknown
Registered
2018-05-02
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity with gastroesophageal reflux disease

Interventions

Experimental group:Laparoscopic sleeve gastrectomy combined with partial fundoplication

Sponsors

People's Hospital Xinjiang Uygur Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Obesity (BMI = 32.5 kg/m2) or mild to moderate obesity (BMI = 27.5 kg/m2) and associated obesity (obstructive sleep apnea syndrome, type 2 diabetes, Hypertension, non-alcoholic steatohepatitis, hyperuricemia, polycystic ovary syndrome, abnormal kidney function, etc.); 2. Waist circumference: male ? 85cm female ? 80cm; waist-hip ratio: male ? 0.9 female ? 0.8; 3. Male or female aged 16-65 years old; 4. Ineffective after lifestyle interventions, physical exercise, and conservative treatment of various drugs; 5. exclude secondary obesity caused by endocrine abnormalities; 6. No serious mental illness and behavioral abnormalities; 7. There is no serious abnormality of major organs; 8. willing to accept surgery, and follow-up postoperative management.

Exclusion criteria

Exclusion criteria: 1. secondary obesity caused by endocrine abnormalities; 2. Patients who abuse drugs, alcohol addiction, have mental disorders that are difficult to control, and lack the ability to understand the risks, benefits, and expected consequences of weight loss surgery; 3. Those who are forbidden for surgery (cardiopulmonary liver, kidney, and other vital organ dysfunction and can not tolerate general anesthesia, surgery; pregnant and lactating women; have pneumoperitoneal contraindications; 4. Patients who do not fit the test for various reasons; 5. Patients with severe mental illness; 6. Patients with other digestive tract and systemic severe organic diseases, infections and other systemic malignancies; 7. Patients taking antacids, gastric mucosal protective agents, bile adsorbents, non-steroidal anti-inflammatory drugs etc. within 3 weeks before enrollment; 8. Huge esophageal hiatal hernia, severe esophagitis (LA-C and LA-D grade), Barrett's esophagus.

Design outcomes

Primary

MeasureTime frame
GerdQ score;Demeester score;

Countries

China

Contacts

Public ContactKelimu·Abudureyimu

People's Hospital of Xinjiang Uygur Autonomous Region

klm6075@163.com+86 13809956075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026